Cardiovascular Risks Associated with Corticosteroid Use

The American College of Rheumatology suggests that corticosteroids may increase cardiovascular risk due to their effects on lipids, glucose tolerance, insulin production and resistance, blood pressure, and obesity 1, 2
Prolonged use of corticosteroids has been associated with dyslipidemia, hypertension, metabolic syndrome, and weight gain, all of which increase the risk of cardiovascular disease 3
The European Society of Cardiology notes that corticosteroids can cause sodium and water retention, potentially leading to worsening heart failure 2

Mechanisms of Corticosteroid-Induced Cardiovascular Risk

The American Heart Association indicates that corticosteroids have dual effects on the cardiovascular system: they can increase the risk of atherosclerosis due to adverse metabolic effects, but may also decrease risk by suppressing inflammation 1, 4
High-dose corticosteroid therapy is associated with a greater cardiovascular risk compared to low-dose therapy 1, 4

The American College of Cardiology recommends using the lowest possible dose of corticosteroids for the shortest duration to minimize adverse cardiovascular effects 1, 4
For patients with established cardiovascular disease or cardiovascular risk factors, corticosteroids should be used with caution and close monitoring 1, 3
Aggressive control of cardiovascular risk factors (hypertension, dyslipidemia, diabetes) is recommended for patients requiring corticosteroid therapy 1, 3

The European Society of Cardiology suggests optimizing anti-anginal treatment with beta-blockers (first-line), nitrates, and/or calcium channel blockers in patients with stable angina who require corticosteroids 5
Selective beta-blockers (such as bisoprolol, metoprolol, or nebivolol) are preferred in patients with respiratory diseases like COPD 2
In patients with angina and pulmonary disease requiring corticosteroids, inhaled corticosteroids should be considered when possible, as they have fewer systemic effects 3

Regular monitoring of blood pressure, lipid levels, and glucose is recommended for patients receiving long-term corticosteroid therapy 3
Consideration of statin and antihypertensive therapy is recommended for patients with risk factors requiring prolonged corticosteroid treatment 6
Patient education on signs and symptoms of angina is crucial for prompt medical attention in case of chest pain 7